FDA Approved: IOFLUPANE I 123 — Supplemental Application (Curium US LLC)

View source ↗

Summary

FDA approved a supplemental application for IOFLUPANE I-123 (DaTSCAN) from Curium US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor
• Parkinson Disease
• Parkinsonian Syndromes

Drugs mentioned

• DaTscan (ioflupane)

Snippet

SUPPL AP for IOFLUPANE I 123 (IOFLUPANE I-123)